Positron Corporation (ID) (POSC)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Positron Corporation Secures Multiple PET-CT Orders from Leading Nuclear Cardiologist Practices

Buffalo, NY, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC:...

Form 8-K - Current report

Form 8-K - Current report

Positron Corporation Announces Its Transition to a Reporting SEC Company

Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC:...

Form 10-12G - Registration of securities [Section 12(g)]

Positron Corporation Enters Industry Partnership Agreement with MedAxiom

Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC:...

Positron Corporation Wins Innovation Award in PET-CT Category from Medical Device Network’s Excellence Awards 2025

Buffalo, NY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC:...

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Current Report Filing (8-k)

  SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549   FORM 8-K...

Amended Statement of Beneficial Ownership (sc 13d/a)

    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549  ...

Current Report Filing (8-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549    ...

Notification That Annual Report Will Be Submitted Late (nt 10-k)

  UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT...

Quarterly Report (10-q)

   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 10-Q   (Mark...